Schedule 13G ownership disclosure

Strongbridge Biopharma plc

Security class unavailable · CUSIP: G85347105

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
914,062
Percent of class
1.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-19-002514
Form type
SC 13G/A
Filer
Strongbridge Biopharma plc
CIK
CIK 1634432
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub